[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606993":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":18,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":18,"enrollmentInfo":60,"targetDuration":18,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"University of Dublin, Trinity College","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Exercise Arm","EXPERIMENTAL","The exercise programme will be prescribed at a moderate intensity (Target Heart rate: 60%-65% Heart Rate Reserve + resting heart rate) for 30 minutes immediately prior to infusion therapy, on their treatment days over 12- weeks. Exercise will be completed on a stationary cycle ergometer. Target heart rate will be adjusted to 50-55% Heart Rate Reserve + resting heart rate if patient is complaining of fatigue\u002Fnausea, is on beta-blockers or if haemoglobin \\\u003C9g\u002FdL. Heart rate monitoring by chest strap using the polar heart rate monitor will allow participants to self-regulate their exercise intensity. Participants should discontinue exercise and await medical review if they develop chest pain, dizziness or pre-syncope, cyanosis or pallor appearance, new musculoskeletal pain.",[13],"Behavioral: Exercise",{"label":15,"type":16,"description":17,"interventionNames":18},"Education only","NO_INTERVENTION","The control group will receive education on the physical activity recommendations during cancer treatment as per standard care",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"BEHAVIORAL","Exercise",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Aoife McGovern","CONTACT","+3531 293 6692","physiotherapy@beaconhospital.ie",[31],{"facility":32,"status":33,"city":34,"state":18,"zip":18,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Beacon Hospital Dublin","RECRUITING","Dublin","Ireland","IE",{"type":38,"coordinates":39},"Point",[40,41],-6.24889,53.33306,{"lat":41,"lon":40},[44],{"name":26,"role":27,"phone":45,"phoneExt":18,"email":46},"+353 (01) 293 6600","Aoife.McGovern@beaconhospital.ie",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Emer Guinan","Associate Professor","100606993","pre-infusion-aerobic-cycling-exercise-for-cardiorespiratory-fitness-in-cancer-patients-100606993",false,"NCT07182773","Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients","PACE-CRC","Inclusion Criteria:\n\n* Aged \\>18.\n\nHistological confirmed diagnosis of stage I to IIIc breast, ovarian, or colorectal cancer.\n\nScheduled to receive chemotherapy ± immunotherapy with curative intent over at least a 12-week period.\n\nMedical clearance from oncologist to partake in regular exercise in accordance with ACSM preparticipation screening algorithm.\n\nAble to use exercise bike independently.\n\nAbility to provide written informed consent.\n\nExclusion Criteria:\n\n* Advanced\u002Fmetastatic disease.\n\nScheduled to receive concurrent chemoradiotherapy.\n\nNew pain or other pain that would preclude ability to use bike.\n\nInability to read and understand English.\n\nDeemed unfit to proceed from results of CPET.\n\nUnstable angina, arrhythmia, hypertension or decompensated heart failure.\n\nDementia or psychiatric illness which would preclude safe independent exercise.\n\nAcute untreated embolus\u002Finfarct.\n\nDissecting aneurysm.\n\nAcute myocarditis or pericarditis.","ALL","18 Years",{"count":61,"type":62},80,"ESTIMATED","INTERVENTIONAL",[65],"NA","Background to this Research Patients who undergo cancer treatment involving chemotherapy or immunotherapy, can experience considerable reductions in their fitness levels. This is a concern, as exercise is a really important part of cancer care. Therefore delivering exercise programmes that support patients during their chemotherapy or immunotherapy treatment will be essential to helping people to maintain their fitness levels. Research is needed to examine the best way to introduce exercise into the patient pathway in a way that is convenient and patient-centred.\n\nThe Specific Questions Being Asked This research project aims to examine the effect of an exercise programme which involves exercising on the cancer treatment day ward with a physiotherapist while waiting for treatment infusion as a safe and effective way of supporting patients to keep fit and active during chemotherapy treatment. The trial will also investigate if it the prescribed moderate intensity exercise for 30 minutes is manageable for patients.\n\nTrial Plan This project will be delivered as a randomised controlled trial. All participants enrolled on the trial will receive information and advice about physical activity during chemotherapy treatment from a physiotherapist with expertise in cancer care. The intervention arm will also complete an exercise session with the physiotherapist on the day of their infusion treatment over a period of 12 weeks.\n\nThe feasibility of this protocol has already been tested in 17 participants with very positive results. The information gained from this initial study will be used to deliver this trial, which will recruit 80 participants. It is hoped that the information gained from this research will provide a practical way of providing supervised exercise training for patients during chemotherapy or immunotherapy that is safe, expert-led and patient centred.",[68],"Cancer",[70,71,72,73],"exercise","cardiorespiratory fitness","chemotherapy","exercise oncology","2026-04-28",{"date":76,"type":77},"2026-05-04","ACTUAL",{"date":79,"type":77},"2025-09-24",{"date":81,"type":62},"2027-09",{"name":5,"class":6},1]